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Aminoglycoside antibiotic phosphotransferases are also serine 
protein kinases 
Denis M Daigle, Geoffrey A McKay, Paul R Thlompson and Gerard D Wright 
Background: Elacterial resistance to aminoglycoside antibiotics occurs 
primarily through the expression of modifying enzymes that covalently alter tl?e 
drugs by 0-phosphorylation, 0-adenylation or N-acetylation. Aminoglycoside 
phosphotransferases (APHs) catalyze the ATP-dependent phosphorylation of 
these antibiotics. Two particular enzymes in this class, APH(3’)-llla and 
AAC(G’)-APH(S”), are produced in gram-positive cocci and have been shown 
to phosphorylate aminoglycosides on their 3’ and 2” hydroxyl groups, 
respectively. The three-dimensional structure of APH (3’)sllla is strikingly similar 
to those of eukaryotic protein kinases (EPKs), and the observation, reported 
previously, that APH(3’)-llla and AAC(G’)-APH(2”) are effectively inhibited by 
EPK inhibitors suggested the possibility that these aminoglycoside kinases 
might phosphorylate EPK substrates. 
Results: Our data demonstrate unequivocally that APHs can phosphorylate 
several EPK substrates and that this phosphorylation occurs exclusively on 
serine residues. Phosphorylation of Ser/Thr protein kinase substrates by APHs 
was considerably slower than phosphorylation of aminoglycosides under 
identical assay conditions, which is consistent with the primary biological roles 
of the enzymes. 
Conclusions: These results demonstrate a functional relationship between 
aminoglycoside and protein kinases, expanding on our previous observations of 
similarities in proiein structure, enzyme mechanism and sensitivity to inhibitors, 
and suggest an evolutionary link between APHs and EPKs. 
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Introduction 
The second hal’f of the century has seen the discovery, 
development and exploitation of antimicrobial agents 
used to treat a wide variety of microorganisms. The use 
of antibiotics in medicine and agriculture has been paral- 
leled by the selection of bacterial resistance to most of 
these drugs, a fact that has emerged as a significant crisis 
in health care [I]. One prevalent form of resistance to 
antibiotics is (enzyme-mediated modification of the 
drugs. For example, aminoglycoside antibiotics are 
detoxified by resistant organisms through chemical mod- 
ification catalyzed by distinct transferases. The FJrnily of 
aminoglycoside antibiotics, which includes kanamycin, 
gentamicin and many others. can be modified by O-phos- 
phorylation, O-adenytation and N-acetylation [Z]. The 
phosphorytation mechanism involves enzymatic transfer 
of the y-phosphate of ATP to an aminoglycoside 
hydroxyl group. The phosphorylated aminoglycoside no 
longer functions as an effective chemotherapeutic agent 
and the organism is therefore able to survive in the pres- 
ence of aminoglycosides. 
One member of this enzyme family, aminoglycoside 
phosphotransferase type IIIa (APH(3’)-IIIa), has been 
cloned from Staphyfococcus auras [3] and Ek:nturococcus fae- 
culls [4], overexpressed in Esrherktiia co/i and purified to 
homogeneity [S]. This enzyme has been shown to inacti- 
vate aminoglycosides by phosphorylating the 3’ and/or 5” 
hydroxyl group of these antibiotics in an ATP-dependent 
manner [5,6]. A second aminogtycoside kinase also found 
in gram-positive cocci, AAC(h’)-APH(2”), is a unique 
bifunctional enzyme with two functional domains pos- 
sessing cistinct activities. The amino terminus of the 
enzyme has aminoglycoside acetyltransferase activity, 
whereas the aminoglycoside kinase activity resides in the 
carboxy-terminal domain [7]. This enzyme inactivates 
aminogly,:oside antibiotics such as kanamycin by phos- 
phorylation of the 2”-hydroxyt and/or acetytation of the 
h’-amino Kroup [8]. 
The three-dimensional structure of the APH(3’)-IIIa has 0 
recently been solved to 2.2 A and been shown to have sig- 
nificant structural similarity to eukaryotic serine/threonine 
(Ser/Thr) and tyrosine (Tyr) protein kinases (EPK) despite 
a I;rck of ~gnificant amino-acid sequence homology (C 10% 
similarity) [9]. The recently determined structure of the 
type IIP phosphatidylinositot phosphate kinase also 
demonstrates overall similarity with EPK and APH [lo], so 
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Table 1 
Protein kinase substrates. 
Substrate Sequence Associated kinase 
MARCKS K 
MARCKS R 
Kemptide 
Casein 
Histone Hl 
Protamine 
MBP 
AC-FKKSFKL-NH, 
AC-FRRSFRL-NH, 
LRRASLG 
poly(Glu,Tyr) 4:l 
p60c-“‘” Substrate II AC-IYGEF-NH, 
PKC 
PKC 
PKA 
Casein kinases 
PKA, PKC, PKG 
PKC 
PKA, PKC, 
MAP kinases 
Csk 
c-Src 
together these enzymes form a larger structurally related 
kinase family. Apart from overall three-dimensional struc- 
tural similarity, the APHs also share a short amino-acid 
Figure 1 
sequence with EPKs. The sequence (His(Gly/Asn)Asp- 
X3,-Arm (H(G/N)DX,_,N; where X is any amino acid) 
from the APHs is homologous in both structure and func- 
tion to the sequence (H/Y)RDX,N from EPK [9]. The 
conserved aspartate (Aspl90, APH(3’)-IIIa numbering), 
when replaced by an alanine by site-directed mutagenesis, 
shows dramatic reduction in enzymatic activity [9], an 
observation that parallels results obtained for various EPKs 
[ 1 l-141. These mutagenesis studies, and the appropriate 
positioning of Asp190 in the active site, implicate this 
residue as a potential active-site base required for substrate 
hydroxyl deprotonation ;and therefore as a residue assisting 
in phosphor-$ transfer. 
The similarities in both the structure and mechanism of 
APH(3’)-IIIa and EPK have been subsequently investi- 
gated through the use of specific EPK inhibitors, including 
flavanoids and isoquinolinesulfonamides [1.5]. The latter 
group are effective competitive inhibitors of ATP and non- 
competitive inhibitors of aminoglycoside substrates of both 
(a) 
W 
Kanamycin A 
MARCKS K 
MARCKS R 
Protamine 
Myelin basic protein 
Kemptide 
Histone Hl 
Casein 
Poly Glu-Tyr 
P~O~-“~ substrate II 
I I I 1 I I / 
0 50 100 150 200 2!50 
Rate (fmollmin) 
50 
40 60 80 100 
Time (min) 
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Protein phosphorylation by aminogiycoside 
phosphotransferases APH(3’)-llla and 
AAC(G’)-APH(2”). Potential substrates 
(50 PM) were incubated with purified enzymes 
for an appropriate amount of time and analyzed 
as described in the Materials and methods 
section. The rate of reaction was determined 
by fitting to a first-order rate equation. 
(a) Specificity of substrate phosphorylation. 
(b) Example of rate determination for the 
AACt6’)-APH(2”)-catalyzed phosphorylation of 
the MARCKS R peptide. 
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APH(3’)-IIIa and AAC(6’)-APH(2”) with Ki values 
< 100 FM for the best derivatives. APHs and EPKs there- 
fore share a similar overall three-dimensional structure, 
chemical mechanism of phosphoryl transfer and sensitivity 
to inhibitors. 
To further investigate and establish the functional and 
mechanistic relationship between APHs and EPKs we 
report here the ability of two APH enzymes to phosphory- 
late known substrates of EPKs. The results demonstrate 
that APHs can act as serine protein kinases. 
Results and discussion 
Protein kinase activity of APHs 
Previous analyses have indicated that APH(3’)-IIIa shares 
three-dimensional structure. chemical mechanism and 
sensitivity to inhibitors with EPKs. Additionally, the 
bifunctional enzyme AAC(h’)-APH(Z”), which shows 
minimal sequence homology with APH(3’)-IIIa (10% 
identity, 21% similarity) and for which a three-dimen- 
sional structure is unknown at present, was also demon- 
strated to be sensitive to EPK inhibitors [15]. The 
structural and Functional similarities between APHs and 
EPKs suggested the possibility that APHs could have the 
capacity to catalyze phosphoryl transfer to an EPK sub- 
strate. We therefore examined various known protein and 
peptide EPK substrates to determine if APHs could act as 
protein kinases. Our choices of EPK substrates were 
selected to investigate overall substrate diversity as well 
as specificity, that is Tyr or Ser/Thr phosphorylation 
(Table 1). Ser/Thr protein kinase specific substrates 
included MARCKS K and hIARCKS R, derivatives of 
myristolated alamine-rich C-kinase substrate (MARCKS) 
protein [16], and protamine, which are all protein kinase 
C (PKC) substrates [17,18], casein, a substrate of casein 
kinase I and II [19], histone HI, a substrate of protein 
kinase A (PKA), PKC and protein kinase G [20], Kemp- 
tide, a PKA substrate [Zl], and myelin basic protein 
QMBP), a substrate of various protein kinases including 
PKA [Z?], PK(: 1231 and mitogen-activated protein 
kinases (~38, p42 and ~44 MAP kinases) [23,24]. Two 
protein Tyr kinase substrates were also analyzed, 
poly(Glu,Tyr) (4:1), a synthetic pepcide substrate for 
various tyrosine kinases (e.g. csk [14]), and pb(Yrc sub- 
strate II, a substrate of c-src kinase [ZS]. These peptides 
and proteins represent a broad spectrum of protein kinase 
activities that subsequently give a specific profile to APH 
protein kinase activities. 
Several of the Ser/Thr kinase substrates, including the 
MARCKS peptides, protamine and MBP, were phospho- 
rylated by both APH(3’)-IIIa and AAC(6’)-APH(2”), 
whereas Kemptide, histone Hl and casein were not sub- 
strates (Figure 1). The tyrosine kinase specific substrates, 
poly(Glu,Tyr) (4:l) or ~60-‘~ substrate II were not sub- 
strates of either APH(3’)-IIIa or AAC(6’)-APH(2”). 
Figure 2 
(a) 
APH(3')-IIIa H188GDLGDSNIFVKDGKVSG-----FIDLG 
AAC(6')-APH(2") H372NDFSC-NHLLLDGNNRLTG---IIDFG 
PKA(yeast TPKl) Y20#?RDLKPENILLDKNGHIK-----ITDFG 
PKC-a Y461RDLKLDNVMLDSEGHIK-----IADFG 
CK-I Y129RDIKPDNFLIGRPSSRN~RG 
c-src H38'7RDLWiANILVGENLVCK-----VADFG 
CDK2 H12!iRDLKPQNLLINTEGAIK-----LADFG 
Active-site region of protein and aminoglycoside kinases. (a) Sequence 
alignment of aminoglycoside and protein kinases highlighting 
conserved residues including Asp1 90 (green, APH(3’)-llla numbering), 
the putative active-site base, and the Mg*+ ligands, Asnl95 (pink) and 
Asp208 (red). Genbank accession numbers: APH(3’)-llla, VO1547; 
AAC(6’)-APH(P”), Ml3771 ; TPKI, Ml 7072; Human PKCa, S09496; 
Schizosaccharomyces pombe CK-1, UO6930, Human pp60c-SrC, 
K03218; Human CDK2, X61 622. lb) Close up of the APH(3’)-llla 
active site displaying ADP (orange) Mg2+ (cyan), the ADP coordinating 
residue Lys44 (light green), Asp1 90 (dark green), Asn195 (magenta), 
Asp208 (red). Gly189 is white. The structure was drawn using the 
programs MOLSCRIPT [38] and RASTER 3D [39]. 
Phosphorylacion of the substrate MBP was also investi- 
gated using specific API-I site mutants with impaired 
aminoglycoside kinase activity in an effort co confirm that 
protein phosphorylation u’as not due to contamination in 
either the enzyme or the substrate preparations. The 
APH(3’)-IIIa Aspl90+Ala and Asp-QO8Ala mutants 
were selected on the basis of the known geometry of the 
active site and precedent in the EPK literature (Figure 2). 
Asp190 is therefore predicted to be involved in phospho- 
ryl transfer and has a dramatically lower k,,, (> SOO-fold) 
for aminoglycoside substrates when converted to alaninc 
[9]. We also prepared the Asp208+Ala mutant as this 
residue co-ordinates Mg-:+ in the ,4PH(3’)-IIIa-ADP 
complex [Y]. The analogous residue in yeast PKA 
(Asp228) ,?as been mutated co alanine and lacks any 
detectable kinase activity, whereas the AspZlO-+Ala 
mutant, which is equivalent to APH(3’) AsplYO, retained 
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Table 2 
- --__ 
Kinetic parameters for mutant APHs. 
Mutant APH Substrate kc&-‘) 
APH(3’)-Illa ATP 0.52 f 0.02 
Glyl 89+Argt Kanamycin A 0.10 f 0.01 
Kanamycin B 0.60 k 0.02 
Neomycin C 0.15*0.01 
Ribostamycin 0.09 f 0.005 
APH(3’)-llla Kanamycin A No activity detected* 
Asp208-+Ala 
AAC(G’)-APH(2”) Kanamycin A 5 0.0019 
Asp374jAla 
______ 
- 
Ratio of kinetic parameters to 
wild-type enzyme* 
-____ 
K&M) k,,,/K,(M-Is-‘) *kc,, *KIT %dK, 
320 f 34 1.6~10~ 0.33 11 1.6 0.025 
1050f310 9.4 x 10’ 0.06 83.3 0.007 
89.6 + 7.0 6.6x 103 0.17 4.60 0.036 
32.3 + 4.5 4.8 x 1 O3 0.07 4.2 0.018 
91.3f 14.3 9.9 x 102 0.05 9.8 0.005 
0.0048 
*Kinetic parameters for the wild-type enzyme were from [51. +Other paromomycin. *Activity was not above background at 1 mM ATP, 
aminoglycosides that were found not to be phosphorylated by the 0.1 mM kanamycln A. Wild-type k,,, 5’ is 0.42 s-l (D.M.D., G.D.W., 
enzyme were amikacin, butirosin, isepamicin, lividomycin and unpublished observations). 
only 0.4% of the wild-type activity, consistent with 
important roles for these residues in catalysis [12]. 
APH(3’)-IIIa AspZW-+Ala lacks any detectable aminogly- 
coside kinase activity, as measured by ADP release 
coupled to pyruvate kinase and lactate dehydrogenase 
(Table 2). Phosphorylation of MBP by these mutant 
APH(3’)-IIIa enzymes was determined following a 4 h 
incubation (Figure 3). ‘I’he Aspl9O+Ala mutant was only 
52% as active as the wild-type enzyme. whereas the 
AspZOX+Ala mutant was completely inactive as assessed 
by scintillation counting of excised phospho-MBP bands; 
protein phosphorylation is therefore due to the action of 
APH(.~‘)-IIIa and not due to contaminating protein kinase 
activity in either the substrate or the enzyme prepara- 
tions. Additionslly, the substrate MBP was boiled prior to 
addition to the reaction mix to inactivate any contaminat- 
ing kinases, and this had no effect on phosphorylation in 
the presence of APHs. Similarly, the Asp374 residue of 
AAC(A’)-APH(;!“) is equivalent, by sequence alignment, 
to Asp190 of APH(3’)-IIIa (Figure Za). This enzyme has a 
greater than 200-fold impaired k,,, for aminoglycoside 
kinase activity using the ADP-release assay (Table 2) and 
also showed significantly diminished MPB phosphoryla- 
tion capacity (6.7% of wild-type, Figure 3a) as expected. 
The fact that some protein phosphorylation activity was 
nonetheless detected in the Asp190 and Asp374 mutants 
reflects the longer incubation times and higher substrate 
concentrations [Ised in this radioactive assay than in the 
spectrophotometric ADP release assay used to detect 
aminoglycoside phosphorylation. 
overall charge of +2 at pi-I 7.5 are not substrates. Nonethe- 
less, the observed specificity is consistent with the fact 
that the substrate-binding pocket for APH(3’)-IIIa (and by 
implication AAC(6’)-APH(2”)) has an overall negative 
charge 1191. LJnder the conditions used to detect activity 
with APHs, the Ser/Thr kinase substrates were phospho- 
rylated by either PKC or casein kinase-I as appropriate. 
These results are all the more surprising when placed in 
the context of the three-dimensional structure of APH(3’)- 
IIIa and EPKs. Although the overall fold of APH(3’)-IIIa 
Figure 3 
2 
APH(3’)-llla 
1 
2 3 
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The peptides and proteins that were phosphorylated by 
APHs have in common overall positive charge: p1 > 10 for 
MARCKS peptides, MBP and protamine. Acidic peptides 
and proteins were not phosphorylated. The basis for dis- 
crimination, however. is not exclusively due to charge as 
histone Hl (pI > 10) and the peptide Kemptide with 
Phosphorylation of MBP by APH(3’)-llla and AAC(G’)-APH(2”). MBP 
was phosphorylated with [y32P]-ATP by (a) AAC(G’)-APH(2”) or 
(b) APH(3’)-llla, separated on a 15% SDS-polyacrylamide gel and 
analyzed by autoradiography. Bovine MBP has a molecular weight of 
18.3 kDa, but when phosphorylated, migrates at/or around 23 kDa. 
(a) Lane 1, wild-type AAC(G’)-APH(2”); lane 2, AAC(G’)-APH(2”) 
Asp374+Asn. (b) Lane 1, wild-type APH(3’)-llla; lane 2, APH(3’)-llla 
Asp1 90+Ala; lane 3, APH(3’)-Illa Asp208dAla. Similar results were 
found with Inative MBP and with MBP which was first boiled to 
inactivate any contaminating kin,sses. 
1 
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Fiaure 4 
Three-dimensional structures of APH(3’)-llla and casein kinase-1 . is blocked in part in APH(3’)-llla by two helices between residues 135 
Comparison of the three-dimensional structures of (a) APH(3Wlla and 176 shown in orange in the APH(3’)-llla structure. (c) Ribbon 
bound to ADP and (b) casein kinase-I bound to ATP (PDB ID code drawing of APH@‘)-llla. A loop region between residues 49-56 that 
1 CSN). The nucleotide cosubstrates are indicated in green and the lines the second substrate binding region of the active site is white. 
Mg*+ ions are in magenta. The large cleft in casein kinase-1, which Structures (a) and (b) were drawn with the program RasMol v 2.6 [40], 
provides access to the active site for the protein and peptide substrates, whereas (c:) was drawn with MOLSCRIPT and RASTER 3D [39]. 
and EPKs is s.lmilar, a significant difference lies in the 
accessibility of I:he active site (Figure 4). In EPKs. such as 
casein kinase-l., the peptide/protein-binding site is open, 
whereas in APH(3’)-IIIa access is limited by several struc- 
tural factors. Chief among these is an additional element in 
the carboxy-terminal domain consisting of two a helices 
that are positioned to provide a steric block to access by 
large substrates (Figure 4). In addition, a loop region con- 
tributed by the amino-terminal domain also serves to block 
access (Figure 4b). Attempts to delete the two tx helices in 
the carboxy-terminal domain of ,4PH(3’)-IIIa have so far 
yielded only insoluble and inactive protein (G.A.M. and 
G.D.W. unpublished observations). Nevertheless, the fact 
that some peptides and proteins are phosphorylated by 
APHs indicates I:he generous capacity of the active site. 
The phosphorylation of MBP was further investigated to 
assess the rate and specificity of reaction. We initially 
attempted to determine V,,, and K, for these subsmAtes 
withour success, as the quantities of peptide required fol 
enzyme saturation were incompatible with the assay. We 
therefore turned to a measure of k,,,/K,,, using a sub-K,,, 
concentration (10 l&l) of MBP with equimolar enzyme. 
LJnder these conditions, the hlichaelis-Menten equation 
simplifies to: 
v  = [Sl[E,,,lk,,dK, (1) 
The values for k,,,/K, for MBP were determined to be 
4.5 X lo? W’s-’ -for APH(3’)-IIIa and 8.0 x lo2 W’s+ for 
AAC(6’)-APH(2”). These catalytic efficiencies are SO- and 
75fold lower respectively than those obtained for 
kanamycin A using the phosphocellulose-binding assay 
under similar reaction conditions. The k,;,,/K,, for PKC-cat- 
alyzed MBP phosphorylation is on the order of 10h iWs-’ 
[26], so APH protein phosphorylation is, as expected, not 
comparable in efficiency with a dedicated protein kinase, 
but nevertheless demonstrates notable activity. 
To further define and characterize the site of phosphoryla- 
tion, phosphoamino acid analysis was performed on 
MARCK,S K, MBP and protamine phosphorylated by 
APH(3’) or AAC(6’)-APH(2”). Phosphorylation of sub- 
strates by both enzymes occurred exclusively on serine 
residues (IFigure S), so APHs are protein Ser kinases. The 
reciproca: reaction, that is phosphorylation of aminoglyco- 
sides by IZPKs, was assayed using purified casein kinase I 
and PKC however no detectable phosphorylation of 
kanamycin A or neomycin C (1 mhl) occurred over 60 min 
(detection limit 0.7 fmol). 
Characterization of APH(3’bllla Glyl89+Arg 
Alignment of EPKs and APHs reveals a common catalytic 
peptide: His-Z-Asp-X,l--Asn (HZDX,,N: where 2 is 
Gly, Asn or Arg, and X is any amino acid; Figure Za), 
where the conserved asplrtate is required for catalysis, 
possibly acting as an actilre-site base, and the conserved 
asparagine is essential for Mg?+ binding. The histidine 
residue is not necessary for catalytic activity in APH(3’)- 
IIIa [27] and indeed can be a tyrosine residue in some 
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Figure 5 
r 
(4 
PO&erine. 
PO,-Threonine 
PO,-Tyrosine 
Chemetry & &dog! 
Phosphoamino acid analysis of MARCKS K 
phosphorylated by AAC(6’)-APH(2”) and 
PKC. MARCKS K was phosphorylated by 
(a) AAC(GYAPH(2”) and (b) PKC, 
hydrolyzed under acidic conditions and 
separated by two-dimensional thin layer 
electrophoresis as described in the Materials 
and methods section. The relative positions of 
standard phosphoserine, phosphothreonine 
and phosphotyrosine are indicated. 
Phosphotylation of MARCKS K, MARCKS R 
and protamine by both APH(3’)-llla and 
AAC(G’)-APH(2”) occurred exclusively on 
serine residues. 
protein kinases. In APHs, the second amino acid, 2, is 
almost exchrsively a glycine residue, although it is 
asparagine in the bifunctional AAC(6’)-APH(2”). On the 
other hand, with very few exceptions, the 2 residue is an 
arginine in EPKs. We therefore mutated the equivalent 
glycine in APH(3’)-IIIa (Gly189) to arginine in an effort to 
determine if this change could impact on the protein 
kinase activity of this enzyme. Surprisingly, mutation of 
this residue abolished protein kinase activity and substan- 
tially disruptled aminoglycoside phosphorylation and 
specificity (Table 2). The drop in activity generally comes 
from both an increase in K, and a decrease in k,,,. This 
suggests that this point mutation has caused significant 
change in the geometry of the active site and demon- 
strates that although EPKs and APHs share significant 
three-dimensional homology, mechanism and, now, sub- 
strate specificity, there nonetheless exist significant differ- 
ences between the enzymes that will require substantial 
effort to unravel. 
Significance 
The data presented here conclusively demonstrate that 
aminoglycoside phosphotransferase (APH) enzymes 
tested in this study have intrinsic protein kinase activity, 
and suggest that other APHs will also retain this prop- 
erty. Thus APHs and eukaqotic protein kinases 
(EPKs) share three-dimensional structural features, 
chemical mechanism of phosphoryl transfer, sensitivity 
to inhibitors, and the capacity to phosphorylate protein 
and peptide substrates. Such similarities are unlikely to 
be due to convergence and suggest a direct evolutionary 
relationship between these enzymes. Recent evidence 
has shown that Ser/Thr and even Tyr kinases are not 
exclusive to eukaryotes and that many bacteria harbor 
such signal transduction enzymes (reviewed in [28,29]). 
In particular, Sermhr kinases have been either cloned 
from, or implicated in secondary metabolism in, actino- 
mycetes [30-341. Members of this group of bacteria are 
also important producers of aminoglycoside antibiotics 
and harbor APH genes themselves [2]. Actinomycetes 
therefore provide a potential common point of origin for 
antibiotic resistance enzymes and protein kinases. 
The biological relevance, if any, of the protein kinase 
activity of APHs is at present unknown. These results 
might, however, impact on both eukaryotic and prokary- 
otic signal transduction experiments performed in which 
aminog,lycoside resistance provides a selectable marker. 
For example the neo (encoding APH(3’)-II) or hyg 
(encoding APH(4)-I) genes confer resistance to the 
aminoglycoside antibiotics G418 and hygromycin B, 
respectively, and are frequently used in eukaryotic gene 
expression experiments. Our observation that two 
related APHs can phosphorylate proteins, although this 
activity is decidedly not robust, should be considered 
during the experimental design. 
Materials and methods 
Chemicals and enzymes 
Myelin-basic protein from bovine brain, Kemptide, casein, poly(Glu,Tyr) 
(4:l) and ltanamycin were from Sigma. Histone Hl from calf thymus and 
p60c-src SlJbstrate II were from Calbiochem. Protamine and MARCKS R 
peptide were the kind gift of Richard Epand, Department of Biochemistry, 
McMaster University. MARCKSK peptide was prepared by R.E. Williams, 
Institute for Biological Sciences, National Research Council, Ottawa, 
Ont. APH(3’)-llla and site mutants were purified as described previously 
151. The details for the overexpression and purification of AAC(G’)- 
APH(2”) will be submitted for p$Jblication. Site mutants were prepared by 
the QuikChange site-directed mutagenesis kit (Stratagene) using primers 
5’sGGGTCCAGCGCCACCClTIlCTG-3’, 5’-ClTCTCCCAAGAGCA- 
ATAAA-GCCAC-3’ and 5’.GTTTATGCCATAATAATllTAGTrGTAATC- 
A-3’, and their reverse complements for APH(3’)-llla Glyl89+Arg, 
APH(3’)-llla Asp208-+Ala, and AAC(G’)-APH(2”) Asp374jAsn 
respectively. Rat brain PKC preparation (a mixture of cw$ and y isoforms) 
was the kind gift of R. Epand, Department of Biochemistry, McMaster 
University. Casein kmase-I from Schizosaccharontyces pombe was 
purified from E. co/i BL21/p1‘7ll-ckiA298 (kind gift of Jeff Kuret, 
Department of Cell and Molecular Biology, Northwestern University 
Medical School, Chicago, IL) as described previously [35]. 
Aminoglycoside kinase assay 
Phosphorylation of aminoglycosides was monitored by coupling the 
release of ADP to the reactions catalyzed by pyruvate kinase and 
lactate dehydrogenase or by phosphocellulose binding assay as 
described previously [5]. 
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Protein kinase assays 
Phosphocellulose binding assay. Phosphorylation of peptide and 
aminoglycoside substrates was monitored by three separate assays. A 
phosphocellulose binding assay was employed for substrates which 
are positively charged at neutral pH and generally amenable to this pro- 
tocol [36]. The assay consisted of peptide substrate (50-l 00 FM final 
concentration for rate determinations and 600 pM for determination of 
linearity with addition of enzyme), or aminoglycoside substrate (50 uM 
final), purified AAC(G’)-APH(2”) (15-60 ug) or purified APH(3’)-llla 
(7.5-30 ug), 10 rnM [~~PI-ATP (1.20 x 1 O5 cpmlnmol), 50 mM Tris 
pH 8.0, 40 mM KCI, 10 mM MgCI,, in a final volume of 10 ~1. The reac- 
tions proceeded at room temperature and were terminated after 5 min 
to 6.5 h by application onto Whatman P-81 phosphocellulose paper 
washed three consecutive times with water, air dried and placed in 
scintillation vials with 5 ml of scintillation fluid. 
G/ass microfibre filter assay. Substrates with a negative or neutral 
charge at neutral pH and or those that weren’t amenable to trapping 
on phosphocellulose paper, were assayed using filtration on glass 
microfibre filters. The reactions were prepared as in the above proce- 
dure. At the appropriate times, samples were applied onto Whatman 
GFlC glass microfibre filters and suction-filtered through a Millipore 
vacuum filtration apparatus. The filters were washed several times with 
the reaction buffer, air dried and placed in scintillation vials with 5 ml 
of scintillation fluid. 
p60C-src Substrate /I activity assays. Assay mixtures were comprised of 
peptide (500 ug/ml), 10 mM [y3*P]-ATP (1.20 x 1 O5 cpmlnmol), 
100 mM Tris-Cl pH 7.5, 10 mM MgCI, and 40 mM KCI. Reactions were 
initiated by the addition of 1 O-20 pg of purified enzyme and incubations 
were allowed to lproceed for O-4 h at ambient temperature. Samples 
were analyzed by reverse phase HPLC using a Spherisorb-ODS2 Cl 8 
column (4 mm x 20 cm) at a flow rate of 0.5 mllmin. Reactions were 
diluted fivefold to ia final volume of 100 pl and applied to the column in a 
solution of 0.1% ttifluoroacetic acid. Peptides were eluted by a gradient 
of 0.07% trifluoroacetic acid in acetonitrile (CHsCN) (B). The gradient 
consisted of 10 minutes 0% B, 0 to 40% B over 50 min, a 10 min hold 
at 40% B followed by 40 to 90% B over 1 min. Eluent was monitored by 
simultaneously monitoring wavelengths from 210 to 300 nm using a 
photodiode array detector. Fractions (0.5 ml) were collected and ana- 
lyzed by scintillation counting. 
Phosphorylafion of histone H7 and MBP. Incubations consisted of 
0.4 mg/ml histone Hl or MBP and 10 mM [y32P]-ATP (1.20 x lo5 
cpmlnmol) in 50 IBM Tris-Cl pH 7.5, 10 mM MgCI,, 40 mM KCI. The 
assays were initiated by the addition of 1 O-20 pg of either APH(3’)llla or 
AAC(G’)-APH(2”) and allowed to progress for 4 h at ambient tempera- 
ture. The samples were quenched by the addition of EDTA to a final con- 
centration of 35 mM followed by an equal volume of 2 x SDS loading 
buffer (100 mM Tris-HCI pH 8.0, 2 mM EDTA, 1 Oo/, glycerol, 4% SDS) 
and separated on ;a 15% SDS-polyacrylamide gel. Phosphorylation of the 
substrates was monitored by autoradiography of the dried gel. 
Protein kinase phosphorylafion of kanamycin. Two protein kinases, 
casein kinase I and PKC, were assayed by phosphocellulose filter 
binding assay for their ability to modify the aminoglycoside kanamycin. 
Assay conditions were identical to those described above with the 
exception that 25 ug of either partially purified casein kinase I or PKC 
were used insteacl of an APH. For PKC activity assays large unilamellar 
vesicles composed of phosphotidylserine and phosphatidylcholine 
were added to a final concentration of 100 FM. The reactions were 
allowed to proceed for l-4 h and then applied to Whatman P81 phos- 
phocellulose paper and analyzed as above. 
Analysis of rate data. Plots of the amount of phosphate incorporated 
into substrate proteins or peptides as a function of time were fit by non- 
linear least squares method to a first order rate equation: 
v=k [Sl (2) 
Phosphoamino acid analysis of phosphorylated products 
Peptides (MARCKS R, MARCKS K and protamine) were first sub- 
jected to an in vitro kinase reaction that consisted of 15 pg of AAC(G’)- 
APH(2”), 32 ug of peptide, [yszPIATP to 10 mM final (1.20x lo5 
cpmlnmol) in 20 pl of 50 mM Tris pH 7.5, 40 mM KCI and 10 mM 
MgCI,. Reactions proceeded for 2 h. Separation of the phosphorylated 
peptide from ATP and enzyms was accomplished by binding to What- 
mann P-131 phosphocellulose paper followed by three consecutive 
washes and drying. 
The dried 1 cm* piece of phosphocellulose was placed in a screw cap 
Eppendof tube with 1 ml of 6N HCI and incubated in a 11 O’C oven for 
90 min. The hydrolysate was evaporated under vacuum and the sample 
was then dissolved in 10 ul of water. 
Separation and identification of phosphoamino acids was performed by 
two-dimensional thin layer electrophoresis (37). A 5 ul volume of the 
sample was applied in 0.5 pi aliquots followed by drying on an origin of 
a 20 cm x 20 cm x 100 urn glass-backed cellulose thin layer chro- 
matography plate. Non-radioactive standard phosphoserine, phospho- 
threonine and phosphotyrosilne were also applied at the origin. The 
buffer for the first dimension of electrophoresis consisted of 50 ml of 
88% formic acid (0.58 M final concentration), 156 ml of glacial acetic 
acid (1.36 M final concentration) and 1794 ml water all at pH 1.9. The 
plate was the electrophoresed for 20 min at 1.5 kV in a Hunter Thin 
Layer Peotide Mapping System Model# HTLE-7000. Following elec- 
trophoresis the plate was removed and air dried. 
The second dimension buffer consisted of 100 ml of glacial acetic acid 
(0.87 M final concentration), 10 ml of pyridine (0.5% (v/v) final concentra- 
tion, 10 IT I of 100 mM EDTA (0.5 mM final concentration) and 1880 ml of 
water all at pH 3.5. The plate was rotated 90” to the first dimension elec- 
trophoresis and re-electrophoresed for 16 min. at 1.3 kV. The plate was 
dried, sprayed with 0.25% ninhydrin in ethanol and heated to visualize 
the standcards. Autoradiography was then used to visualize the samples. 
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